# Alefacept in Patients With Relapsed/Refractory Aplastic Anemia

> **NCT01267643** · PHASE1 · TERMINATED · sponsor: **The Cleveland Clinic** · enrollment: 4 (actual)

## Conditions studied

- Aplastic Anemia

## Interventions

- **DRUG:** Alefacept

## Key facts

- **NCT ID:** NCT01267643
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2011-05
- **Primary completion:** 2011-12-16
- **Final completion:** 2013-04-16
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** Study drug not available at this time
- **Last updated:** 2018-01-26

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01267643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01267643, "Alefacept in Patients With Relapsed/Refractory Aplastic Anemia". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01267643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*